Our combined analysis of CDK12-defective public domain data and our cohort study indicate that low expression of MHC in primary tumor clones are often linked to structural alterations, such as somatic CN-LOH and LOH subclonal genomic alterations. The gene discussed is CDK12; the disease is neoplasm.